BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7106265)

  • 1. The C-terminal tetrapeptide of cholecystokinin decreases hunger in rats.
    Halmy L; Nyakas C; Walter J
    Experientia; 1982 Jul; 38(7):873-4. PubMed ID: 7106265
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholecystokinin reduces exploratory behavior in mice.
    Crawley JN; Hays SE; Paul SM; Goodwin FK
    Physiol Behav; 1981 Sep; 27(3):407-11. PubMed ID: 6278520
    [No Abstract]   [Full Text] [Related]  

  • 3. CCK4 contains the full hormonal information of cholecystokinin in isolated pancreatic acini.
    Sankaran H; Bailey AC; Willaims JA
    Biochem Biophys Res Commun; 1981 Dec; 103(4):1356-62. PubMed ID: 6174128
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of cholecystokinin-related peptides on retention of passive avoidance behaviour.
    Fekete M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1982; 60(4):237-42. PubMed ID: 6314742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the rat.
    Agnati LF; Fuxe K; Benfenati F; Celani MF; Battistini N; Mutt V; Cavicchioli L; Galli G; Hökfelt T
    Neurosci Lett; 1983 Feb; 35(2):179-83. PubMed ID: 6304577
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of cholecystokinin tetra and octa peptides on locomotor activity in mice.
    Takeda Y; Takano Y; Kamiya H
    Jpn J Pharmacol; 1986 Sep; 42(1):145-9. PubMed ID: 3795615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic analogs of cholecystokinin terminal tetrapeptide that stimulate insulin but not glucagon release from pancreatic islets.
    Khalid P; Sharma SD; Khan MM; Rastogi AK; Kidwai JR; Mathur KB
    Acta Diabetol Lat; 1986; 23(3):239-42. PubMed ID: 3538737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of insulin secretion by peptides analogous to the C-terminal tetrapeptide amide of cholecystokinin.
    Ahmad N; Sharma SD; Rastogi AK; Kidwai JR; Mathur KB
    Acta Diabetol Lat; 1984; 21(4):361-4. PubMed ID: 6397026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
    Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a centrally selective cholecystokinin analog on male, Sprague Dawley rats in the non-fasted food intake model.
    Wire WS; Fang SN; Hruby VJ; Finch ST; Kramer TH; Burks TF
    Proc West Pharmacol Soc; 1991; 34():453-9. PubMed ID: 1788328
    [No Abstract]   [Full Text] [Related]  

  • 11. [Exocrine secretion of pancreas after the administration of ceruletide diethylamine, cholecystokinin-pancreozymin and tetragastrin in rats (author's transl)].
    Hosaka Y
    Nihon Ika Daigaku Zasshi; 1981 Jun; 48(3):370-6. PubMed ID: 7298821
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholecystokinin-octapeptide effects on eating elicited by "external" versus "internal" cues in rats.
    Schallert T; Pendergrass M; Farrar SB
    Appetite; 1982 Jun; 3(2):81-90. PubMed ID: 6291458
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and biological activity of partially modified retro-inverso pseudopeptide derivatives of the C-terminal tetrapeptide of gastrin.
    Rodriguez M; Dubreuil P; Bali JP; Martinez J
    J Med Chem; 1987 May; 30(5):758-63. PubMed ID: 3572963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin inhibits tail pinch-induced eating in rats.
    Nemeroff CB; Osbahr AJ; Bissette G; Jahnke G; Lipton MA; Prange AJ
    Science; 1978 May; 200(4343):793-4. PubMed ID: 565535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the behavioral activity of C- and N-terminal fragments of cholecystokinin octapeptide.
    Crawley JN; St-Pierre S; Gaudreau P
    J Pharmacol Exp Ther; 1984 Aug; 230(2):438-44. PubMed ID: 6086888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
    Fiedorowicz RJ; Wiśniewski K
    Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of sulfated and unsulfated cholecystokinin octapeptide on conditioned feeding behaviour in rats.
    Fekete M; Balázs M; Penke B; Telegdy G
    Peptides; 1981; 2(4):385-8. PubMed ID: 6276866
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholecystokinin decreases food intake in rats.
    Gibbs J; Young RC; Smith GP
    J Comp Physiol Psychol; 1973 Sep; 84(3):488-95. PubMed ID: 4745816
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of cholecystokinin tetrapeptide amide on the metabolism of 5-hydroxytryptamine in the rat brain.
    Itoh S; Takashima A; Katsuura G
    Neuropharmacology; 1988 Apr; 27(4):427-31. PubMed ID: 2458532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of C-terminal tetrapeptide cholecystokinin (CCK-4) on the function of the islands of Langerhans and the adenohypophysis].
    Fedotov VP; Sadovnikova NV; Gudoshnikov VI; Batrameeva LA; Aleshina LV
    Biull Eksp Biol Med; 1984 Jun; 97(6):729-31. PubMed ID: 6146360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.